Ten-year graft survival of deceased-donor kidney transplantation: a single-center experience

REFERENCES

• Abbaszadeh S, Nourbala MH, Taheri S, Renal transplantation from deceased donor in Iran. Saudi J Kidney Dis Transpl. 2008;19(4):664–668.
   PubMedGoogle Scholar
• Abboud O. Incidence, prevalence and treatment of end stage renal disease in the Middle East. Ethn Dis. 2006;16(Suppl. 2): S2-2–S2-4.
   Google Scholar
• Mahdavi-Mazdeh M, Heidari-Rouchi A, Aghighi M, Organ and tissue transplantation in Iran. Saudi J Kidney Dis Transpl. 2008;19(1):127–131.
   PubMedGoogle Scholar
• Mahdavi-Mazdeh M, Heidary-Rouchi A, Norozi S, Renal replacement therapy in Iran. Urol J. 2007;4:66–70.
   PubMedGoogle Scholar
• Schena FP. Epidemiology of end stage renal disease: International comparisons of renal replacement therapy. Kidney Int. 2000;57:39–45.
   Web of Science ®Google Scholar
• Hariharan S, Johnson CP, Barbara A, Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612.
   PubMed Web of Science ®Google Scholar
• Cacho DT, Cusi LIP, Pique AA, Elderly donor kidney transplant: Factors involved in graft survival. Transplant Proc. 2005;37:3690–3992.
   PubMedGoogle Scholar
• Kriesche HUM, Port FK, Ojo AO, Effect of waiting time on renal transplant outcome. Kidney Int. 2000;58:1311–1317.
   PubMedGoogle Scholar
• Shrestha BM, Haylor JL. Factors influencing long term outcome following renal transplantation: A review. J Nepal Med Assoc. 2007;46(167):136–142.
   PubMedGoogle Scholar
• Ghods AJ. Renel transplantation in Iran. Nephrol Dial Transplant. 2002;17:222–228.
   PubMed Web of Science ®Google Scholar
• Foster CE, Weng RR, Pharm D, The influence of organ acceptance criteria on long term graft survival: Outcome of a kidney transplant program. Am J Surg. 2008;195:149–152.
   PubMedGoogle Scholar
• Tan SY, Chen TP, Lee SH, Cadaveric renal transplantation at university hospital Kuala Lumpur: A preliminary report. Transplant Proc. 2000;32:1811–1812.
   PubMedGoogle Scholar
• Cecka JM. The UNOS renal transplant registry. Clin Transplant. 2001;7;1–18.
   Google Scholar
• Meier-Kriesche HU, Cibrik OM, Ojo AO, Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc. 2002;50:14–17.
   PubMed Web of Science ®Google Scholar
• Denton MD, Singh AK. Recurrent and de novo glomerulonephritis in the renal allograft. Semin Nephrol. 2000;20:164–175.
   PubMedGoogle Scholar
• Womer KL, Vella JP, Sayegh MH. Chronic allograft dysfunction: Mechanisms and new approaches to therapy. Semin Nephrol. 2000;20:126–147.
   PubMed Web of Science ®Google Scholar
• Ojo AO, Hanson JA, Wolfe RA, Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000;57:307–313.
   PubMed Web of Science ®Google Scholar
• Takemoto SK, Terasaki PI, Gjertson DW, Twelve years’ experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med. 2000;343:1078–1084.
   PubMed Web of Science ®Google Scholar
• Kwon OJ, Ha MK, Kwak JY, The impact of delayed graft functions on graft survival in living donor kidney transplantation. Transplant Proc. 2003;35:92–93.
   PubMed Web of Science ®Google Scholar
• Mange K, Feldman H. Blood pressure and prediction of patient outcome. Kidney Int. 2000;57:2655.
   PubMedGoogle Scholar
• Akioka K, Takahara S, Ichikawa S, Factors predicting long-term graft survival after kidney transplantation: Multicenter study in Japan. World J Surg. 2005;29:249–256.
   PubMedGoogle Scholar
• Meier-Kriesche HU, Arndorfer JA, Kaplan B, The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation. 2002;73:70–74.
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Kaplan B. Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with Sandimmune. Am J Transplant. 2002;2:100–104.
   PubMed Web of Science ®Google Scholar
• Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States 2004. Am J Transplant. 2005;5(4 Pt. 2):843–849.
   PubMedGoogle Scholar
• Pugliese O, Quintieri F, Mattucci DA, Venettoni S. Kidney graft survival in Italy and factors influencing it. Prog Transplant. 2005;15(4):385–391.
   PubMedGoogle Scholar
• Truan Cacho D, Peri Cusí LI, Agud Piqué A, Elderly donor kidney transplant: Factors involved in graft survival. Transplant Proc. 2005;37:3690–3692.
   PubMedGoogle Scholar
• Wu C, Evans I, Joseph R, Comorbid conditions in kidney transplantation: Association with graft and patient survival. J Am Soc Nephrol. 2005;16:3437–3444.
   PubMed Web of Science ®Google Scholar
• Giblin L, O’Kelly P, Little D, A comparison of long-term graft survival rates between the first and second donor kidney transplanted–the effect of a longer cold ischemic time for the second kidney. Am J Transplant. 2005;5:1071.
   PubMedGoogle Scholar
• Einollahi B. Iranian experience with the non-related renal transplantation. Saudi J Kidney Dis Transpl. 2004;15(4): 421–428.
   PubMedGoogle Scholar
• Meier-Kriesche HU, Li S, Gruessner RW, Immunosuppression: Evolution in practice and trends, 1994–2004. Am J Transplant. 2006;6(5 Pt. 2):1111–1131.
   PubMed Web of Science ®Google Scholar
• Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 1995;60:225.
   PubMed Web of Science ®Google Scholar
• Shapiro R, Jordan ML, Scantlebury VP, A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999;67:411.
   PubMed Web of Science ®Google Scholar
• Ojo AO, Meier-Kriesche HU, Hanson JA, Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation. 2000;69:2405.
   PubMed Web of Science ®Google Scholar
• Ciancio G, Miller J, Gonwa TA. Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation. 2005;80:S191.
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Cravedi P, Costantini M, Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: The MYSS follow-up randomized, controlled clinical trial. J Am Soc Nephrol. 2007;18:1973.
   PubMed Web of Science ®Google Scholar
• Shapiro R, Jordan ML, Scantlebury VP, Reducing the length of stay after kidney transplantation – the intensive outpatient unit. Clin Transplant. 1998;12:482.
   PubMedGoogle Scholar
• Lin S-J, Koford JK, Baird BC, The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin Transplant. 2006;20:245–252.
   PubMedGoogle Scholar